Literature DB >> 31060998

IL-28B genetic variation, gender, age, jaundice, hepatitis C virus genotype, and hepatitis B virus and HIV co-infection in spontaneous clearance of hepatitis C virus.

Sergii V Fedorchenko1, Anna Klimenko1, Tetyana Martynovich1, Olga Liashok1, Vitaliy Yanchenko1.   

Abstract

BACKGROUND/AIMS: Spontaneous viral clearance observed in some patients is one of the variants of the hepatitis C virus (HCV) infection natural history. We aimed to look at the complexity of factors affecting the spontaneous clearance of HCV (SC HCV).
MATERIALS AND METHODS: A total of 357 anti-HCV positive patients (309 with chronic hepatitis C and 48 patients with SC HCV) were included into the study. We studied the effects of the interleukin-28B (IL-28B) gene polymorphism, gender, age, the routes of virus transmission, past hepatitis C with jaundice, HCV genotype, and hepatitis B virus (HBV) and HIV co-infection on the outcome of HCV infection.
RESULTS: Based on the study results, the SC HCV was found in 48 individuals (13.4%). The most significant positive factors affecting the SC HCV included IL-28B single nucleotide polymorphism (SNP) rs12979860 (CC) and SNP rs8099917 (TT) (OR 4.03, p<0.001) and (OR 3.14, p<0.002), female gender (OR 2.72, p<0.001), young age (OR 2.30, p<0.008), and past history of jaundice (OR 5.12, p<0.001). The markers of a past HBV infection were found significantly more often in SC.
CONCLUSION: Positive predictors of the SC HCV include favorable IL-28B genotype, female gender, young age, a history of jaundice, markers of a past HBV infection, the absence of HIV infection, but not the viral genotype.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31060998      PMCID: PMC6505656          DOI: 10.5152/tjg.2019.18328

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  30 in total

1.  Higher clearance of hepatitis C virus infection in females compared with males.

Authors:  I Bakr; C Rekacewicz; M El Hosseiny; S Ismail; M El Daly; S El-Kafrawy; G Esmat; M A Hamid; M K Mohamed; A Fontanet
Journal:  Gut       Date:  2006-01-24       Impact factor: 23.059

2.  Hepatitis C virus reinfection in injection drug users.

Authors:  Jason Grebely; Brian Conway; Jesse D Raffa; Calvin Lai; Mel Krajden; Mark W Tyndall
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

3.  Hepatitis C viral genotype influences the clinical outcome of patients with acute posttransfusion hepatitis C.

Authors:  S J Hwang; S D Lee; R H Lu; C W Chu; J C Wu; S T Lai; F Y Chang
Journal:  J Med Virol       Date:  2001-11       Impact factor: 2.327

4.  Hepatitis C viral clearance in an intravenous drug-using cohort in the Dublin area.

Authors:  S Keating; S Coughlan; J Connell; B Sweeney; E Keenan
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

5.  Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?

Authors:  H E Harris; K P Eldridge; S Harbour; G Alexander; C-G Teo; M E Ramsay
Journal:  J Viral Hepat       Date:  2007-03       Impact factor: 3.728

6.  Spontaneous clearance of childhood hepatitis C virus infection.

Authors:  L T F Yeung; T To; S M King; E A Roberts
Journal:  J Viral Hepat       Date:  2007-11       Impact factor: 3.728

7.  Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.

Authors:  Chia C Wang; Elizabeth Krantz; Jared Klarquist; Meighan Krows; Lanamarie McBride; Edward P Scott; Thomas Shaw-Stiffel; Scott J Weston; Hanne Thiede; Anna Wald; Hugo R Rosen
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

8.  Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease.

Authors:  Flavia Bortolotti; Gabriella Verucchi; Calogero Cammà; Giuseppe Cabibbo; Lucia Zancan; Giuseppe Indolfi; Raffaella Giacchino; Matilde Marcellini; Maria Grazia Marazzi; Cristiana Barbera; Giuseppe Maggiore; Pietro Vajro; Samuela Bartolacci; Fiorella Balli; Anna Maccabruni; Maria Guido
Journal:  Gastroenterology       Date:  2008-03-02       Impact factor: 22.682

9.  Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.

Authors:  Jason Grebely; Jesse D Raffa; Calvin Lai; Mel Krajden; Brian Conway; Mark W Tyndall
Journal:  Can J Gastroenterol       Date:  2007-07       Impact factor: 3.522

10.  Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance.

Authors:  Daniel Yerly; David Heckerman; Todd M Allen; John V Chisholm; Kellie Faircloth; Caitlyn H Linde; Nicole Frahm; Joerg Timm; Werner J Pichler; Andreas Cerny; Christian Brander
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.